Zobrazeno 1 - 10
of 810
pro vyhledávání: ''
Autor:
C. Meyer, Y. Fouché, Emmanuel Chamorey, M. Dejode, C. Bailleux, J. Haudebourg, Renaud Schiappa, Y. Delpech, Emmanuel Barranger
Publikováno v:
Clinical Breast Cancer. 22:121-126
Background Delays in initiating adjuvant chemotherapy after breast cancer surgery seems to have an impact on patients’ risk of relapse and their survival rate. The aim of this retrospective study was to identify factors delaying initiation of adjuv
Autor:
Chih Bin Lin, Chao Hua Chiu, Kang Yun Lee, Wen Hui Ku, Yen-Ting Lin, Yu-Feng Wei, Shang Yin Wu, Jian Su, Mei Hsuan Lee, Jen Yu Hung, Jin-Yuan Shih, Chi Lu Chiang, Hsin Pei Chung, Wu Chou Su, Yen Han Tseng, Tsai Shin Chiang
Publikováno v:
European Journal of Cancer. 156:1-11
Introduction Anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) crizotinib, ceritinib, alectinib, brigatinib, and lorlatinib are approved for advanced non–small-cell lung cancer (NSCLC) with ALK rearrangement. However, the mechanism
Autor:
Shusuke Akamatsu, Hideaki Takada, Ryoichi Saito, Takayuki Goto, Akihiro Hamada, Toru Sakatani, Takeshi Sano, Yuki Kita, Kei Mizuno, Keiyu Matsumoto, Osamu Ogawa, Kenji Nakamura, Takashi Kobayashi, Tatsuaki Tsuruyama, Kaoru Murakami
Publikováno v:
Cancer Science
Overcoming cisplatin (CDDP) resistance is a major issue in urothelial cancer (UC), in which CDDP‐based chemotherapy is the first‐line treatment. WEE1, a G2/M checkpoint kinase, confers chemoresistance in response to genotoxic agents. However, the
Autor:
Daniela A. Bota, Thomas H. Taylor, David E. Piccioni, Christopher M. Duma, Renato V. LaRocca, Santosh Kesari, Jose A. Carrillo, Mehrdad Abedi, Robert D. Aiken, Frank P. K. Hsu, Xiao-Tang Kong, Candace Hsieh, Peter G. Bota, Gabriel I. Nistor, Hans S. Keirstead, Robert O. Dillman
Publikováno v:
Journal of experimental & clinical cancer research : CR, vol 41, iss 1
Background Vaccine immunotherapy may improve survival in Glioblastoma (GBM). A multicenter phase II trial was designed to determine: (1) the success rate of manufacturing the Aivita GBM vaccine (AV-GBM-1), (2) Adverse Events (AE) associated with AV-G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d452687f27f51d3fa6d821c2d61a207
https://doi.org/10.21203/rs.3.rs-2117699/v1
https://doi.org/10.21203/rs.3.rs-2117699/v1
Publikováno v:
American Journal of Clinical Oncology. 44:519-525
OBJECTIVES The POLO (Pancreas Cancer Olaparib Ongoing) trial demonstrated improvement in progression-free survival (PFS) with olaparib maintenance in advanced pancreatic cancer (APC) patients with germline BRCA1/2 mutations who had disease control af
Autor:
Robert A. Wolff, Ching Wei D. Tzeng, Michael J. Overman, Chirayu Mohindroo, Shubham Pant, Milind Javle, Wenli Dong, Gauri R. Varadhachary, Michael T. Lotze, Matthew H.G. Katz, Merve Hasanov, David R. Fogelman, Seyda Baydogan, Jane E. Rogers, Florencia McAllister, Michael P. Kim, Jonathan D. Mizrahi, Laura R. Prakash
Publikováno v:
Cancer Medicine, Vol 10, Iss 15, Pp 5041-5050 (2021)
Cancer Medicine
Cancer Medicine
Recent studies defined a potentially important role of the microbiome in modulating pancreatic ductal adenocarcinoma (PDAC) and responses to therapies. We hypothesized that antibiotic usage may predict outcomes in patients with PDAC. We retrospective
Autor:
Kwonoh Park, Sang-Bo Oh, Joo Yeon Jang, Jin Hyeok Kim, So Yeon Oh, Yun Jeong Hong, Ki Sun Jung, Ung-Bae Jeon, Jae-Joon Kim, Eun Ju Park
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative care (HPC) unit is acceptable in terms of safety and efficacy and whether it results
Autor:
James S. Blachly, Uma Borate, Eunice S. Wang, Bhavana Bhatnagar, Ross L. Levine, Ann-Kathrin Eisfeld, Amy Burd, John C. Byrd, Richard Stone, Brian J. Druker, Alice S. Mims, Krzysztof Mrόzek, Eytan M. Stein, Bayard L. Powell, Jonathan E. Kolitz, Clara D. Bloomfield, Shelley Orwick, Jessica Kohlschmidt, Dimitrios Papaioannou, Deedra Nicolet
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-15 (2021)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
Background Older patients (≥ 60 years) with acute myeloid leukemia (AML) often have multiple, sequentially acquired, somatic mutations that drive leukemogenesis and are associated with poor outcome. Beat AML is a Leukemia and Lymphoma Society-spons
Autor:
Antonia Strippoli, Alessandra Cocomazzi, Carmelo Pozzo, Maria Alessandra Calegari, Michele Basso, Riccardo Ricci, Carlo Barone, Mariantonietta Di Salvatore, I. Zurlo, Mattia Schino, Giampaolo Tortora, Maurizio Martini, Alessandra Cassano, Luigi Maria Larocca, Emilio Bria
Publikováno v:
Cancer Immunology, Immunotherapy
The combination of perioperative chemotherapy plus complete surgical resection is currently accounted as the first-choice strategy in patients with locally advanced Gastric Cancer (LAGC). Nevertheless, the partial response rate makes it necessary to
Publikováno v:
Clinical Lung Cancer. 22:e193-e200
Background Many studies have shown that invasive pulmonary aspergillosis, cryptococcosis, and mucormycosis can mimic radiographic and clinical features of primary lung cancer. However, more research surveying the incidence and outcomes of these funga